Ember Therapeutics Stock Market Value
| EMBT Stock | USD 0.0001 0.00 0.00% |
| Symbol | Ember |
Ember Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ember Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ember Therapeutics.
| 04/28/2025 |
| 07/27/2025 |
If you would invest 0.00 in Ember Therapeutics on April 28, 2025 and sell it all today you would earn a total of 0.00 from holding Ember Therapeutics or generate 0.0% return on investment in Ember Therapeutics over 90 days. Ember Therapeutics is related to or competes with Insteel Industries, Worthington Steel, ArcelorMittal, Seche Environnement, CECO Environmental, Amgen, and Corning Incorporated. Ember Therapeutics, Inc. operates as a clinical stage biopharmaceutical company More
Ember Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ember Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ember Therapeutics upside and downside potential and time the market with a certain degree of confidence.
Ember Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ember Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ember Therapeutics' standard deviation. In reality, there are many statistical measures that can use Ember Therapeutics historical prices to predict the future Ember Therapeutics' volatility.Ember Therapeutics Backtested Returns
We have found three technical indicators for Ember Therapeutics, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Ember Therapeutics are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Ember Therapeutics has perfect predictability. Overlapping area represents the amount of predictability between Ember Therapeutics time series from 28th of April 2025 to 12th of June 2025 and 12th of June 2025 to 27th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ember Therapeutics price movement. The serial correlation of 1.0 indicates that 100.0% of current Ember Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Ember Therapeutics lagged returns against current returns
Autocorrelation, which is Ember Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ember Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Ember Therapeutics returns to help us make a trade decision. For example, suppose you find that Ember Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ember Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ember Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ember Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ember Therapeutics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Ember Therapeutics Lagged Returns
When evaluating Ember Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ember Therapeutics pink sheet have on its future price. Ember Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ember Therapeutics autocorrelation shows the relationship between Ember Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Ember Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ember Pink Sheet Analysis
When running Ember Therapeutics' price analysis, check to measure Ember Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ember Therapeutics is operating at the current time. Most of Ember Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ember Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ember Therapeutics' price. Additionally, you may evaluate how the addition of Ember Therapeutics to your portfolios can decrease your overall portfolio volatility.